Business
Press Release Nov 03 2020
Cadila Healthcare Limited has informed the Exchange regarding a press release dated November 03, 2020, titled "Zydus announces IND filing of ZYIL1, a novel oral small molecule NLRP3 inflammasome inhibitor".
About this update from Zydus Lifesciences Limited
[{"type":"text","content":" Cadila Healthcare Limited has informed the Exchange regarding a press release dated November 03, 2020, titled \"Zydus announces IND filing of ZYIL1, a novel oral small molecule NLRP3 inflammasome inhibitor\". View Attachment","length":359,"tagName":"div"}]